Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anouk Dev

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Gastroenterology|March 15, 2020
Innate Immune Molecule NLRC5 Protects Mice From Helicobacter-induced Formation of Gastric Lymphoid TissueMichelle Chonwerawong, Jonathan Ferrand, Hassan Mohammad Chaudhry, et al.
BMC Cancer|May 31, 2020
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisationGauri Mishra, Anouk Dev, Eldho Paul, et al.
Hepatology Communications|May 2, 2024
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitisNatassia Tan, Natalie Ngu, Thomas Worland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 15, 2021
Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC studyWilliam Kemp, Ammar Majeed, Joanne Mitchell, et al.
Hepatology International|August 25, 2022
Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort studyKurvi Patwala, David Stephen Prince, Yael Celermajer, et al.
Cancers|December 23, 2023
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie Ngu, et al.
Cancers|September 14, 2024
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Cancers|June 19, 2024
Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
BMC Cancer|July 7, 2024
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)Alan Wigg, Jonathan Tibballs, Richard Woodman, et al.
Hepatology Communications|September 25, 2022
Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensusAshika D Maharaj, John Lubel, Eileen Lam, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Gastroenterology|March 15, 2020
Innate Immune Molecule NLRC5 Protects Mice From Helicobacter-induced Formation of Gastric Lymphoid TissueMichelle Chonwerawong, Jonathan Ferrand, Hassan Mohammad Chaudhry, et al.
BMC Cancer|May 31, 2020
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisationGauri Mishra, Anouk Dev, Eldho Paul, et al.
Hepatology Communications|May 2, 2024
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitisNatassia Tan, Natalie Ngu, Thomas Worland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 15, 2021
Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC studyWilliam Kemp, Ammar Majeed, Joanne Mitchell, et al.
Hepatology International|August 25, 2022
Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort studyKurvi Patwala, David Stephen Prince, Yael Celermajer, et al.
Cancers|December 23, 2023
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie Ngu, et al.
Cancers|September 14, 2024
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
Cancers|June 19, 2024
Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie L Ngu, et al.
BMC Cancer|July 7, 2024
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC)Alan Wigg, Jonathan Tibballs, Richard Woodman, et al.
Hepatology Communications|September 25, 2022
Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensusAshika D Maharaj, John Lubel, Eileen Lam, et al.
Pageof 7